Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지
DOI QR코드

DOI QR Code

Therapeutic Potentiality of Celtis choseniana Nakai on Androgenic Alopecia through Repression of Androgen Action and Modulation of Wnt/β-catenin Signaling

  • Hui-Ju Lee (Department of Veterinary Medicine & Institute of Veterinary Science, Chungnam National University) ;
  • Geum-Lan Hong (Department of Anatomy, College of Medicine, Konyang University) ;
  • Kyung-Hyun Kim (Department of Veterinary Medicine & Institute of Veterinary Science, Chungnam National University) ;
  • Yae-Ji Kim (Department of Veterinary Medicine & Institute of Veterinary Science, Chungnam National University) ;
  • Tae-Won Kim (Department of Veterinary Medicine & Institute of Veterinary Science, Chungnam National University) ;
  • Ju-Young Jung (Department of Veterinary Medicine & Institute of Veterinary Science, Chungnam National University)
  • Received : 2022.11.28
  • Accepted : 2023.03.01
  • Published : 2023.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

In this study, we investigated the efficacy of Celtis choseniana Nakai (C. choseniana) as complementary herbal medicine to ameliorate androgenic alopecia (AGA). The effects of C. choseniana on AGA were evaluated using testosterone propionate-induced AGA mouse model and dihydrotestosterone-treated human hair follicle dermal papilla cells. In vivo, C. choseniana treatment deactivated androgen signaling by reducing the concentration of serum dihydrotestosterone level and expressions of 5α-reductase 2 and androgen receptor. Next, C. choseniana treatment increased the hair regrowth rate. Histological studies demonstrated that C. choseniana induced the anagen phase in testosterone propionate-induced AGA mouse model. Cellular proliferation was promoted by C. choseniana treatment via increasing the expression of proliferation factors, such as proliferating cell nuclear antigen and cyclin D1. Furthermore, C. choseniana treatment increased the expression of proteins related to the Wnt/β-catenin signaling pathway. In addition, dickkopf-1, a Wnt inhibitor, was downregulated with C. choseniana treatment. Likewise, C. choseniana treatment promoted cellular proliferation in vitro. This study demonstrated the inhibitory effect of C. choseniana on androgen-induced AGA. Moreover, C. choseniana induced activation of Wnt/β-catenin signaling, resulting in prolonged anagen and cellular proliferation. Therefore, we suggest that C. choseniana can be used as a therapeutic agent to alleviate AGA.

Keywords

References

  1. Hong, G. L.; Kim, T. W.; Lee, H. J.; Kim, Y. J.; Kim, K. H.; Jung, J. Y. Chin. J. Nat. Med. 2022, 20, 518-526. 
  2. Liu, Y.; Wang, X.; Chen, Q.; Luo, L.; Ma, M.; Xiao, B.; Zeng, L. Mol. Nutr. Food Res. 2020, 64, e1900943. 
  3. Kim, H. G.; Choi, S.; Lee, J.; Hong, Y. H.; Jeong, D.; Yoon, K.; Yoon, D. H.; Sung, G. H.; Lee, S.; Yi, K.; Kim, J. H.; Cho, J. Y. Evid. Based Complement. Alternat. Med. 2018, 2018, 3909038. 
  4. Alonso, L.; Fuchs, E. J. Cell Sci. 2006, 119, 391-393.  https://doi.org/10.1242/jcs.02793
  5. Grymowicz, M.; Rudnicka, E.; Podfigurna, A.; Napierala, P.; Smolarczyk, R.; Smolarczyk, K.; Meczekalaski, B. Int. J. Mol. Sci. 2020, 21, 5342. 
  6. Lolli, F.; Pallotti, F.; Rossi, A.; Fortuna, M. C.; Caro, G.; Lenzi, A.; Sansone, A.; Lombardo, F. Endocrine 2017, 57, 9-17.  https://doi.org/10.1007/s12020-017-1280-y
  7. Hibberts, N.; Howell, A. E.; Randall, V. A. J. Endocrinol. 1998, 156, 59-65.  https://doi.org/10.1677/joe.0.1560059
  8. Kaufman, K. D.; Olsen, E. A.; Whiting, D.; Savin, R.; DeVillez, R.; Bergfeld, W.; Price, V. H.; Van Neste, D.; Roberts, J. L.; Hordinsky, M.; Shapiro, J.; Binkowitz, B.; Gormley, G. J. J. Am. Acad. Dermatol. 1998, 39, 578-589.  https://doi.org/10.1016/S0190-9622(98)70007-6
  9. Sheikh, S.; Ahmad, A.; Ali, S. M.; Ahmad, M. U.; Paithankar, M.; Saptarshi, D.; Kale, P.; Maheshwari, K.; Barkate, H. V.; Pathak, H. L.; Mushtaq, M.; Ahmad, I. J. Clin. Exp. Dermatol. Res. 2015, 6, 253. 
  10. Dallob, A. L.; Sadick, N. S.; Unger, W.; Lipert, S.; Geissler, L. A.; Gregoire, S. L.; Nguyen, H. H.; Moore, E. C.; Tanaka, W. K. J. Clin. Endocrinol. Metab. 1994, 79, 703-706. 
  11. Drake, L.; Hordinsky, M.; Fiedler, V.; Swinehart, J.; Unger, W. P.; Cotterill, P. C.; Thiboutot, D. M.; Lowe, N.; Jacobson, C.; Whiting, D.; Stieglitz, S.; Kraus, S. J.; Griffin, E. I.; Weiss, D.; Carrington, P.; Gencheff, C.; Cole, G. W.; Pariser, D. M.; Epstein, E. S.; Tanaka, W.; Dallob, A.; Vandormael, K.; Geissler, L.; Waldstreicher, J. J. Am. Acad. Dermatol. 1999, 41, 550-554. 
  12. Urysiak-Czubatka, I.; Kmiec, M. L.; Broniarczyk-Dyla, G. Postepy Dermatol. Alergol. 2014, 31, 207-215. 
  13. Premanand, A.; Rajkumari, B. R. Arch. Dermatol. Res. 2018, 310, 391-399.  https://doi.org/10.1007/s00403-018-1826-8
  14. Fu, D.; Huang, J.; Li, K.; Chen, Y.; He, Y.; Sun, Y.; Guo, Y.; Du, L.; Qu, Q.; Miao, Y.; Hu, Y. Biomed. Pharmacother. 2021, 137, 111247. 
  15. Kang, J. I.; Kim, M. K.; Lee, J. H.; Jeon, Y. J.; Hwang, E. K.; Koh, Y. S.; Hyun, J. W.; Kwon, S. Y.; Yoo, E. S. Mar. Drugs 2017, 15, 130. 
  16. Choi, H.; Lee, Y.; Shin, S. H.; Nam, J.; Park, W. S.; Park, B. C.; Kim, B. J. Biomed. Rep. 2022, 16, 16. 
  17. Bak, D. H.; Lee, E.; Lee, B. C.; Choi, M. J.; Kwon, T. R.; Kim, J. H.; Park, B. C.; Lee, K.; Kim, S.; Na, J.; Kim, B. J. Exp. Dermatol. 2020, 29, 341-348.  https://doi.org/10.1111/exd.14051
  18. Kim, D.; Garza, L. A. J. Invest. Dermatol. 2017, 137, 2248-2250.  https://doi.org/10.1016/j.jid.2017.07.826
  19. Kitagawa, T.; Matsuda, K. I.; Inui, S.; Takenaka, H.; Katoh, N.; Itami, S.; Kishimoto, S.; Kawata, M. J. Clin. Endocrinol. Metab. 2009, 94, 1288-1294.  https://doi.org/10.1210/jc.2008-1053
  20. Kishimoto, J.; Burgeson, R. E.; Morgan, B. A. Genes Dev. 2000, 14, 1181-1185.  https://doi.org/10.1101/gad.14.10.1181
  21. Lu, G. Q.; Wu, Z. B.; Chu, X. Y.; Bi, Z. G.; Fan, W. X. Medicine 2016, 95, e4297. 
  22. Lee, Y. R.; Bae, S.; Kim, J. Y.; Lee, J.; Cho, D. H.; Kim, H. S.; An, I. S.; An, S. J. Microbiol. Biotechnol. 2019, 29, 1830-1840.  https://doi.org/10.4014/jmb.1908.08018
  23. Kwack, M. H.; Kim, M. K.; Kim, J. C.; Sung, Y. K. J. Invest. Dermatol. 2012, 132, 1554-1560.  https://doi.org/10.1038/jid.2012.24
  24. Elliott, K.; Stephenson, T. J.; Messenger, A. G. J. Invest. Dermatol. 1999, 113, 873-877.